Measurement of Energy Metabolism in Infants
Pennington Biomedical Research Center · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT02683473
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 1 mo–4 mo · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 70
- US sites recruiting
- 1
- Study start
- March 16, 2016
- Record last updated
- August 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.
Conditions: Infant Development; Infant Overnutrition
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy, full-term infant
- Aged 1 month (28 days) to 3 months (12 weeks, 6 days) at the first visit
- Exclusively fed breast milk and/or infant formula
- Willing to accept doubly-labeled water
Exclusion Criteria
- Unable to complete 3 clinic visits within about 14 days at Pennington Biomedical Research Center
- Born preterm (\< 37 weeks gestation)
- Congenital abnormality or disability
- Gastric reflux
- Acute illness within 7 days of the study (fever, diarrhea)
- Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence or reflux such as Pepcid)
Recruiting US locations
Pennington Biomedical Research Center
Baton Rouge, LA 70808
Site contact: Abby Altazan, M.S. · (225) 763-2801 · abby.altazan@pbrc.edu
Study contacts (from the official record)
- Abby Altazan, M.S. · (225) 763-2801 · abby.altazan@pbrc.edu
Similar studies in Louisiana
All nutrition & metabolism studies in Louisiana →- RecruitingHealthy volunteersPhase 1/Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals
- Location
- Marrero, LA + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- New Orleans, LA + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Covington, LA + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Lafayette, LA + 112 other US sites
- Eligibility basics
- Ages 18–75